---
title: 'Director, Corporate Counsel at Cogent Biosciences'
canonical: 'https://feeny.ai/job/director-corporate-counsel-cogent-biosciences-waltham-massachusetts-re6398tj5cwt'
type: 'job'
last_seen: '2026-09-16'
---

# Director, Corporate Counsel at Cogent Biosciences

- **Company:** Cogent Biosciences
- **Location:** Waltham Massachusetts, United States
- **Work type:** remote
- **Posted:** 2026-09-10
- **Last confirmed live:** 2026-09-16
- **Apply:** https://job-boards.greenhouse.io/cogentbiosciences/jobs/4400755009

## Job description

Who We Are:

Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.

The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST.  In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025.  The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025.  The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.

Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.

The Role:

This is a broad, hands-on role for an attorney who will join a growing legal department and serve as counsel in connection with various types of contracts supporting business needs, including strategic transactions, research collaborations, services arrangements and other legal needs as the company transitions into a commercial-stage biotech company and its other pipeline programs evolve. The Corporate Counsel will partner closely with cross-functional teams to support transactional matters, including drafting, reviewing, and negotiating a portfolio of agreements; advising internal clients on strategic business development projects; and ensuring compliance with applicable laws, while helping mitigate legal risk and enable business growth in a fast-paced biotechnology environment. Reporting to the Associate General Counsel, this position will work with multiple functional areas and assist on a broad range of legal matters across the organization.

Responsibilities:

- Draft, review, negotiate, and manage a wide variety of agreements, including confidentiality agreements, master service agreements, statements of work, sponsorship agreements, consulting agreements, clinical trial agreements, vendor and supplier agreements, collaboration and licensing agreements, and sponsored research agreements.
- Collaborate with colleagues across commercial, medical affairs, research, clinical operations, finance, and senior leadership to provide business-focused legal advice that balances risk with company objectives.
- Monitor changes in applicable laws and regulations and advise on regulatory and legal matters affecting existing or proposed arrangements.
- Coordinate with the company’s data privacy officer on data privacy matters.
- Partner with members of the Legal team to develop and maintain contract templates, legal playbooks, as well as training and guidance documents.

Qualifications:

- Juris Doctor (J.D.) from an accredited law school and active membership in good standing with at least one U.S. state bar.
- 5-7 years of legal experience in the biotechnology/pharmaceutical industry, including experience with an in-house legal department.
- Broad experience drafting and negotiating complex agreements, including agreements supporting research, development, manufacturing, commercial, and other operational functions.
- Experience supporting commercial and/or medical affairs departments in biotechnology, pharmaceutical, life sciences, or healthcare companies strongly preferred.
- Familiarity with domestic and foreign laws governing clinical research, drug development, and data privacy preferred.
- Excellent written and verbal communication, negotiation, attention to detail, and organizational skills, allowing for an open and effective collaboration throughout the company.
- Proven ability to independently lead legal matters and negotiations, advise senior stakeholders, manage multiple priorities, and operate effectively in a fast-paced, collaborative, and growth-oriented environment.

This is primarily a remote role; however, ability to attend on-site monthly team meetings and other activities, preferred.

Salary Range:

$250,000 - 290,000 USD

Target Bonus: 20%

Exact compensation will vary based on skills, experience, and location.

Our Locations

Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building.

Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor.  Our CEO is based full-time in this location and we are proud to call this the home of Cogent’s discovery research organization.

Our Offer To You

To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.

## About Cogent Biosciences

## Company Overview
- **One-liner**: Cogent Biosciences is a publicly traded biotechnology company developing precision therapies for genetically defined diseases, with its lead program bezuclastinib targeting KIT D816V mutations in systemic mastocytosis and gastrointestinal stromal tumors.
- **Entity Type**: Public (NASDAQ: COGT)
- **Headquarters**: Waltham, Massachusetts, United States (with additional office in Boulder, Colorado)
- **Founded**: 2014
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology research and therapeutics development
- **Target customers**: Patients with genetically defined diseases, healthcare providers, and pharmaceutical partners (B2B/B2C hybrid)
- **Mission**: “To discover, develop, and commercialize best-in-class therapies that have a dramatic impact for patients with genetically defined diseases” [cogentbio.com](https://www.cogentbio.com/)

## Products & Services
- **Bezuclastinib**: A selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation and other KIT exon 17 mutations. In late-stage clinical development for advanced systemic mastocytosis (AdvSM), non‑advanced SM, and advanced gastrointestinal stromal tumors (GIST). Positive registration‑directed trial results reported in 2025. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Novel JAK2 V617F inhibitor**: A potential best‑in‑class mutant‑selective JAK2 inhibitor currently in preclinical development, with data presented at the 2026 EHA Congress. [cogentbio.com](https://www.cogentbio.com/)
- **Additional pipeline programs**: Research‑stage targeted therapies addressing mutations in ErbB2, PI3Kα, KRAS, and JAK2. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Market Standing
- **Valuation/Market Cap**: USD $762.7 million (as of mid‑2026, based on LinkedIn data) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Key Metric**: Annual revenue of USD $7.9 million (likely from partnerships or grants); total funding to date ~USD $1.82 billion (including post‑IPO equity, debt, and Series A). [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Notable Investors/Partners**: Series A led by Atlas Venture and F‑Prime; post‑IPO equity rounds led by Commodore Capital (2024, $225M), Fairmount Funds Management (2020, $104.4M) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Growth Signals**: Headcount grew 27.6% year‑over‑year to 223 employees; monthly LinkedIn follower growth of 3.0% (+61.7% annually); positive late‑stage trial results in 2025; expanded pipeline with new preclinical assets. [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)

## Competitive Advantages
- **Selective targeting of KIT D816V**: Bezuclastinib is designed to selectively and potently inhibit the key driver mutation in systemic mastocytosis, potentially offering a better safety/tolerability profile than earlier multi‑kinase inhibitors.
- **Late‑stage momentum**: Registration‑directed trials (APEX pivotal trial) have reported clinically meaningful results, positioning the company for potential regulatory submissions and commercialization.
- **Broad pipeline beyond KIT**: Research into JAK2, KRAS, PI3Kα, and ErbB2 mutations diversifies the platform and reduces single‑asset risk.
- **Strong capital position**: Over $760M market cap and access to public equity markets provide financial runway for multiple programs.

## Strategic Focus
- **Advance bezuclastinib to market**: Continue regulatory interactions and preparation for potential FDA approval in AdvSM and GIST, while expanding into non‑advanced SM.
- **Build a portfolio of precision therapies**: Invest in early‑stage discovery (Boulder, CO) to generate novel molecules targeting validated oncogenic drivers.
- **Commercial readiness**: Hiring commercial leadership (Chief Commercial Officer, Market Access, Field Medical Affairs) indicates preparation for a future product launch. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Why Work Here
- **Culture**: Emphasizes collaboration, urgency, inquisitiveness, and ingenuity. Corporate values include “Patients are waiting” (urgency), “Learning excites us” (inquisitiveness), “Succeed Together” (trust), and “Navigate uncertainty” (ingenuity). [cogentbio.com](https://www.cogentbio.com/careers/)
- **Work model**: Hybrid/remote flexibility – many roles are listed as remote (e.g., Area Directors for Field Medical Affairs, Patient Educators), while research roles are onsite in Boulder, CO. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Growth and impact**: As a late‑stage clinical company with an expanding pipeline, employees have direct influence on programs that could change patient lives. Fast‑paced environment with high autonomy.

## Sources
1. [Cogent Biosciences Corporate Website](https://www.cogentbio.com/)
2. [Cogent Biosciences About Page](https://www.cogentbio.com/about/)
3. [Cogent Biosciences Careers Page](https://www.cogentbio.com/careers/)
4. [Cogent Biosciences Job Board (Greenhouse)](https://job-boards.greenhouse.io/cogentbiosciences)
5. [Cogent Biosciences LinkedIn Profile](https://www.linkedin.com/company/cogentbiosciences)

## Other roles at Cogent Biosciences

- [Research Associate, Pharmacology & Cell Biology](https://feeny.ai/job/research-associate-pharmacology-cell-biology-cogent-biosciences-boulder-colorado-6t4r2c47nb6t) — Boulder Colorado, United States
- [Associate Director, Translational Medicine](https://feeny.ai/job/associate-director-translational-medicine-cogent-biosciences-waltham-rj8yex8parvp) — Waltham Massachusetts, United States
- [Associate Director, Clinical Operations](https://feeny.ai/job/associate-director-clinical-operations-cogent-biosciences-waltham-massachusetts-ae9494b3zdm7) — Waltham Massachusetts, United States
- [Senior Manager, Medical Information](https://feeny.ai/job/senior-manager-medical-information-cogent-biosciences-united-states-je8kfksdfe70) — United States
- [Senior Manager, Quality Control GMP](https://feeny.ai/job/senior-manager-quality-control-gmp-cogent-biosciences-united-states-wdgyhgjzbkmw) — United States
- [Director, Drug Substance Manufacturing & Development](https://feeny.ai/job/director-drug-substance-manufacturing-development-cogent-biosciences-united-3xsj3y1318p1) — United States
- [Associate Director, Patient Marketing](https://feeny.ai/job/associate-director-patient-marketing-cogent-biosciences-waltham-massachusetts-rfrx7rz2grmj) — Waltham Massachusetts, United States
- [Senior Medical Science Liaison - Midwest (Detroit, Minneapolis, Central Plains)](https://feeny.ai/job/senior-medical-science-liaison-midwest-detroit-minneapolis-central-plains-6y8fsqpt0n2k) — United States
- [Principal Scientist, Computational Chemistry](https://feeny.ai/job/principal-scientist-computational-chemistry-cogent-biosciences-boulder-colorado-f1xwrgthyhmq) — Boulder Colorado, United States
- [Desktop and Field Sales Support Specialist](https://feeny.ai/job/desktop-and-field-sales-support-specialist-cogent-biosciences-waltham-m2sxf462656q) — Waltham Massachusetts, United States